News | Mammography | November 08, 2017

ICPME Makes EQUIP Mammography Inspection CME/CE Webinar Available Online

FDA EQUIP analysis shows 44 percent of MQSA inspections revealed deficiencies in mammographic quality assessment processes

ICPME Makes EQUIP Mammography Inspection CME/CE Webinar Available Online

November 8, 2017 — In conjunction with Breast Cancer Awareness Month, the International Center for Postgraduate Medical Education (ICPME) announced the certified webinar, "A Critical Mammography Inspection Update: The Impact of EQUIP," is available online for CME/CE credit. Attended by more than 2,900 breast center directors, lead interpreting physicians, interpreting physicians and radiologic technologists to date, the free one-hour recorded webinar is now available on the ICPME web page.

The EQUIP (Enhancing Quality Using the Inspection Program) initiative was launched by the U.S. Food & Drug Administration (FDA) in October 2016 to coincide with the 25th anniversary of the passage of the Mammography Quality Standards Act (MQSA). Accredited breast screening providers must now address three new questions to ensure compliance with regulations relating to quality assurance in the FDA's annual facility inspections, showing evidence of:

1. A corrective action system to address clinical images of poor quality;

2. A regular review of clinical images by each technologist and each interpreting physician including attributes such as positioning and compression; and

3. A procedure for oversight of QA/QC records and corrective actions.

The FDA recently released a six-month analysis of inspections performed between January and June of 2017. Of the more than 4,100 annual MQSA inspections performed, 44 percent had one or more EQUIP question shortcomings. The highest number of deficiencies was related to Question 2, regarding periodic image quality review. According to the FDA, while many facilities engage in daily feedback, few facilities have adequate quality control procedures and systems in place for ongoing review of image quality.

The ICPME EQUIP webinar was delivered by faculty member Bonnie Rush, RT(R)(M)(QM), a noted educator, consultant, lecturer and writer with long-term experience in regulatory compliance. The webinar was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. This webinar has been designated for 1.0 AMA PRA Category 1 Credit(s) for physicians and for 1.0 hour of ARRT Category A continuing education credit.

The webinar was supported by an independent, educational grant from Volpara Solutions.

For more information: www.icpme.us

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...